PURPOSE: Optical coherence tomography (OCT) is an optical imaging method that can visualize cellular and extracellular structures at and below tissue surface. The objective of the study was to determine if OCT could characterize preneoplastic changes in the bronchial epithelium identified by autofluorescence bronchoscopy. EXPERIMENTAL DESIGN: A 1.5-mm fiberoptic probe was inserted via a bronchoscope into the airways of 138 volunteer heavy smokers participating in a chemoprevention trial and 10 patients with lung cancer to evaluate areas that were found to be normal or abnormal on autofluorescence bronchoscopy. Radial scanning of the airways was done to generate OCT images in real time. Following OCT imaging, the same sites were biopsied for pathologic correlation. RESULTS: A total of 281 OCT images and the corresponding bronchial biopsies were obtained. The histopathology of these areas includes 145 normal/hyperplasia, 61 metaplasia, 39 mild dysplasia, 10 moderate dysplasia, 6 severe dysplasia, 7 carcinoma in situ, and 13 invasive carcinomas. Quantitative measurement of the epithelial thickness showed that invasive carcinoma was significantly different than carcinoma in situ (P=0.004) and dysplasia was significantly different than metaplasia or hyperplasia (P=0.002). In addition, nuclei of the cells corresponding to histologic results became more discernible in lesions that were moderate dysplasia or worse compared with lower-grade lesions. CONCLUSION: Preliminary data suggest that autofluorescence bronchoscopy-guided OCT imaging of bronchial lesions is technically feasible. OCT may be a promising nonbiopsy tool for in vivo imaging of preneoplastic bronchial lesions to study their natural history and the effect of chemopreventive intervention.
PURPOSE: Optical coherence tomography (OCT) is an optical imaging method that can visualize cellular and extracellular structures at and below tissue surface. The objective of the study was to determine if OCT could characterize preneoplastic changes in the bronchial epithelium identified by autofluorescence bronchoscopy. EXPERIMENTAL DESIGN: A 1.5-mm fiberoptic probe was inserted via a bronchoscope into the airways of 138 volunteer heavy smokers participating in a chemoprevention trial and 10 patients with lung cancer to evaluate areas that were found to be normal or abnormal on autofluorescence bronchoscopy. Radial scanning of the airways was done to generate OCT images in real time. Following OCT imaging, the same sites were biopsied for pathologic correlation. RESULTS: A total of 281 OCT images and the corresponding bronchial biopsies were obtained. The histopathology of these areas includes 145 normal/hyperplasia, 61 metaplasia, 39 mild dysplasia, 10 moderate dysplasia, 6 severe dysplasia, 7 carcinoma in situ, and 13 invasive carcinomas. Quantitative measurement of the epithelial thickness showed that invasive carcinoma was significantly different than carcinoma in situ (P=0.004) and dysplasia was significantly different than metaplasia or hyperplasia (P=0.002). In addition, nuclei of the cells corresponding to histologic results became more discernible in lesions that were moderate dysplasia or worse compared with lower-grade lesions. CONCLUSION: Preliminary data suggest that autofluorescence bronchoscopy-guided OCT imaging of bronchial lesions is technically feasible. OCT may be a promising nonbiopsy tool for in vivo imaging of preneoplastic bronchial lesions to study their natural history and the effect of chemopreventive intervention.
Authors: Luc Thiberville; Sophie Moreno-Swirc; Tom Vercauteren; Eric Peltier; Charlotte Cavé; Genevieve Bourg Heckly Journal: Am J Respir Crit Care Med Date: 2006-10-05 Impact factor: 21.405
Authors: I W Park; I I Wistuba; A Maitra; S Milchgrub; A K Virmani; J D Minna; A F Gazdar Journal: J Natl Cancer Inst Date: 1999-11-03 Impact factor: 13.506
Authors: I I Wistuba; C Behrens; A K Virmani; G Mele; S Milchgrub; L Girard; J W Fondon; H R Garner; B McKay; F Latif; M I Lerman; S Lam; A F Gazdar; J D Minna Journal: Cancer Res Date: 2000-04-01 Impact factor: 12.701
Authors: Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Michael J Thun Journal: CA Cancer J Clin Date: 2007 Jan-Feb Impact factor: 508.702
Authors: Suzanne C Whiteman; Ying Yang; Daniel Gey van Pittius; Mark Stephens; Jitendra Parmer; Monica A Spiteri Journal: Clin Cancer Res Date: 2006-02-01 Impact factor: 12.531
Authors: Beau A Standish; Victor X D Yang; Nigel R Munce; Louis-Michel Wong Kee Song; Geoffrey Gardiner; Annie Lin; Youxin I Mao; Alex Vitkin; Norman E Marcon; Brian C Wilson Journal: Gastrointest Endosc Date: 2007-08 Impact factor: 9.427
Authors: Hamid Pahlevaninezhad; Anthony M D Lee; Alexander Ritchie; Tawimas Shaipanich; Wei Zhang; Diana N Ionescu; Geoffrey Hohert; Calum MacAulay; Stephen Lam; Pierre Lane Journal: Biomed Opt Express Date: 2015-09-30 Impact factor: 3.732
Authors: Lida P Hariri; David C Adams; Matthew B Applegate; Alyssa J Miller; Benjamin W Roop; Martin Villiger; Brett E Bouma; Melissa J Suter Journal: Clin Cancer Res Date: 2019-06-07 Impact factor: 12.531
Authors: Hamid Pahlevaninezhad; Anthony M D Lee; Tawimas Shaipanich; Rashika Raizada; Lucas Cahill; Geoffrey Hohert; Victor X D Yang; Stephen Lam; Calum MacAulay; Pierre Lane Journal: Biomed Opt Express Date: 2014-08-06 Impact factor: 3.732
Authors: Lida P Hariri; Matthew B Applegate; Mari Mino-Kenudson; Eugene J Mark; Brett E Bouma; Guillermo J Tearney; Melissa J Suter Journal: J Vis Exp Date: 2013-01-22 Impact factor: 1.355
Authors: Kathleen L Vincent; Nigel Bourne; Brent A Bell; Gracie Vargas; Alai Tan; Daniel Cowan; Lawrence R Stanberry; Susan L Rosenthal; Massoud Motamedi Journal: Sex Transm Dis Date: 2009-05 Impact factor: 2.830
Authors: Tuqiang Xie; Gangjun Liu; Kelly Kreuter; Sari Mahon; Henri Colt; David Mukai; George M Peavy; Zhongping Chen; Matthew Brenner Journal: J Biomed Opt Date: 2009 Nov-Dec Impact factor: 3.170